ClearPoint Neuro’s mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. The ClearPoint® Neuro Navigation System has FDA clearance, is CE-marked, and is installed in 60 active clinical sites in the US and expanding into the EU. The SmartFlow® cannula is being used in partnership with over 20 biologics & drug delivery companies in various stages from preclinical research to late stage regulatory trials. More than 4,000 cases have been supported by our field-based clinical specialist team which offers support and services for our partners.
PPD, part of Thermo Fisher Scientific, is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Over the past five years, PPD has conducted more than 40 gene therapy studies, utilizing multiple vectors and administration routes. Our experience in gene therapy crosses all therapeutic areas, with key strengths in neuroscience and rare diseases. We apply innovative technologies, therapeutic expertise and a firm commitment to quality to bend the cost and time curve of drug development and optimize value.
Biomere is a global, nonclinical contract research organization (CRO) with locations on the east and west coast, as well as multiple locations in China (JOINN). We specialize in solving preclinical challenges with unique solutions. Our globality, personal approach and our drive to expedite research timelines, makes us ideally suited to support our clients’ needs.
PackGene Biotech, as an international AAV packaging supplier (one of the largest in the world), started up in Massachusetts. PackGene focuses on services of the rAAV-based gene therapy CDMO-from plasmid to rAAV in clinical-grade, rAAV packaging in research-grade, lentivirus packaging, vector cloning, etc. Our services aim to provide efficient, cost-effective, high-quality viral delivery solutions for gene and cell therapy, as well as clinical trials at various scale levels. PackGene has been building up its reputation by First-class Quality · Efficient Supply · Assured Service
The Jackson Laboratory
The Jackson Laboratory (www.jax.org) is an independent, nonprofit biomedical research institution, with a National Cancer Institute-designated Cancer Center and more than 2,400 employees. With locations in Bar Harbor, Maine, Sacramento, Calif., and a genomic medicine institute in Farmington, Conn, its mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.
As pioneers in neuroscience, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological diseases as well as related therapeutic adjacencies. Today, Biogen has a leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, and developed the first and only approved treatment to address a defining pathology of Alzheimer’s disease. Biogen is focusing on advancing one of the industry’s most diversified pipelines in neuroscience that will transform the standard of care for patients in several areas of high unmet need.
Neurochase aims to bring transformative therapies to patients with neurological diseases using state of the art technology. Specialising in creating bespoke therapeutic strategies for the direct delivery of gene and other therapies using Convection Enhanced Delivery (CED). Neurochase is developing globally scalable delivery solutions for the pharmaceutical and biotech industry, enabling them to deliver gene and other therapies safely and effectively.
CENTOGENE’s mission is to provide data-driven, life-changing answers to patients, physicians, and pharma companies for rare and neurodegenerative diseases. We integrate multiomic technologies with the CENTOGENE Biodatabank – providing dimensional analysis to guide the next generation of precision medicine. Our unique approach enables rapid and reliable diagnosis for patients, supports a more precise physician understanding of disease states, and accelerates and de-risks targeted pharma drug discovery, development, and commercialization.
Beacon Targeted Therapies
We are a clinical trial and pipeline database solution designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth, and real-time information in the rapidly evolving drug development landscape. For more information or to request a demo, visit our website.